This Review discusses the challenges in accurately identifying rare prostate circulating tumour cells or bone marrow-derived disseminated tumour cells and the resulting need for prostate-specific, sensitive biomarkers for the detection of these cells in liquid biopsy samples.
- Emma E. van der Toom
- Haley D. Axelrod
- Kenneth C. Valkenburg